norethindrone has been researched along with Atypical Endometrial Hyperplasia in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (47.37) | 18.7374 |
| 1990's | 13 (22.81) | 18.2507 |
| 2000's | 12 (21.05) | 29.6817 |
| 2010's | 4 (7.02) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeldayem, HM; Girbash, EF; Radwan, AM; Sherif, HE | 1 |
| Bordi, G; Caserta, D; Mallozzi, M; Matteucci, E; Moscarini, M; Ralli, E | 1 |
| Abdel-Raouf, SM; Abdeldayem, HM; Arafa, EM; Atwa, K; Girbash, EF; Nooh, AM | 1 |
| Adamo, EB; Altavilla, D; Bitto, A; D'Anna, R; Giordano, D; Granese, R; Maisano, D; Marini, H; Nicotina, PA; Squadrito, F; Triolo, O; Villari, D | 1 |
| Akgul, MA; Bozkurt, U; Haberal, A; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Barlow, DH; Bragg, AJ; Campbell, MJ; O'Brien, K; Sturdee, DW; Ulrich, LG; Vessey, MP; Wells, M | 1 |
| Kempfert, NJ; Portman, DJ; Symons, JP; Wilborn, W | 1 |
| HAWKINS, DF | 1 |
| KISTNER, RW | 1 |
| CHARLES, D | 1 |
| CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
| RIZKALLAH, T; TAYMOR, ML | 1 |
| Barlow, DH; Bragg, AJ; Campbell, MJ; O'Brien, K; Sturdee, DW; Ulrich, LS; Vessey, MP; Wells, M | 1 |
| Koninckx, PR; Spielmann, D | 1 |
| Eren, S; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Birkhaeuser, MH; Bodmer, C; Fuchs, G; Kraenzlin, ME; Lippuner, K; Popp, AW; Senn, C; Wyss, H | 1 |
| Ellman, H; Rowan, JP; Simon, JA; Speroff, L | 1 |
| Arguinzoniz, M; Boschitsch, E; Concin, H; De Geyter, C; Ehrenborg, A; Heikkinen, J; Hobson, R; Ibarra de Palacios, P; Samsioe, G; Scheurer, C; Schmidt, G | 1 |
| Casey, CL; Murray, CA | 1 |
| Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Beliaeva, LA; Bukhvalov, IB; Raikhlin, NT; Zheleznov, BI | 2 |
| Cardozo, L; Cooper, DJ; Gibb, DM; Studd, JW; Thom, MH; Tuck, SM | 1 |
| Studd, JW; Thom, MH | 1 |
| Beliaeva, LA; Zheleznov, BI | 2 |
| Boyd, ME; Colgan, TJ; Ferenczy, A; Fugere, P; Lorrain, J; Ross, AH | 1 |
| Khait, OV; Tumasyan, KP; Zaporozhan, VN | 1 |
| Cerin, A; Heldaas, K; Moeller, B | 1 |
| Christensen, A; Damber, MG; Hirvonen, E; Milsom, I; Saure, A | 1 |
| Genant, H; Rowan, J; Speroff, L; Symons, J; Wilborn, W | 1 |
| Aoki, T; Fukatsu, T; Kaba, S | 1 |
| Bajo, J; Folgueira, G; Haya, J; Ortega, P; Pérez-Medina, T | 1 |
| Andersson, K; Karlsson, K; Lagrelius, A; Lindgren, R; Mattsson, LA; Risberg, B; Sandin, K | 1 |
| Archer, DF; Dain, MP; Furst, K; Tipping, D; Vandepol, C | 1 |
| Bjarnason, K; Cerin, A; Lindgren, R; Weber, T | 1 |
| Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
| Arce, J; Archer, DF; Félix, JC; Kurman, RJ; Moyer, DL; Nanavati, N | 1 |
| Anderson, MC; Barlow, DH; Bragg, AJ; Campbell, MJ; Nielsen, B; Sturdee, DW; Ulrich, LG; Vessey, MP; Wells, M | 1 |
| Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
| Paterson, ME; Studd, JW; Sturdee, DW; Thom, MH; Wade-Evans, T; White, PJ; Williams, RM | 1 |
| Stryker, JC | 1 |
| Studd, J; Thom, M; White, PJ | 1 |
| Böhm, W; Carol, W; Hempel, E; Klinger, G | 1 |
| de Koos, EB; Dewhurst, CJ; Haines, RM | 1 |
| Berg, G; Hammar, M; Lindgren, R; Pryse-Davies, J; Risberg, B | 1 |
| Samedova, NCh; Uvarova, EV; Vikhliaeva, EM | 1 |
| Krafft, W | 1 |
| Iakimenko-Vasiutina, EA; Khait, OV | 1 |
| Griesinger, R; Schindler, AE | 1 |
| Cortés-Gallegos, V; González-Diddi, M; Martínez-Meza, MT; Santiago-Payán, H; Sojo-Aranda, I | 1 |
| Miyawaki, Y; Sugimoto, O; Ueki, M | 1 |
| Calderón, JJ; García, G; Maqueo, M | 1 |
| Zussman, L | 1 |
| Cox, JE | 1 |
| Darragh, A | 1 |
3 review(s) available for norethindrone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Topics: Bone Density; Endometrial Hyperplasia; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic | 2006 |
HT update: spotlight on estradiol/norethindrone acetate combination therapy.
Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism | 2008 |
Progestagens in bitches: a review.
Topics: Animals; Depression, Chemical; Dog Diseases; Dogs; Endometrial Hyperplasia; Endometritis; Estrus; Female; Medroxyprogesterone; Megestrol; Norethindrone; Pregnancy; Progestins; Pseudopregnancy; Reproduction | 1970 |
23 trial(s) available for norethindrone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Male; Nandrolone; Norethindrone; Norethindrone Acetate | 2023 |
Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Disease Management; Endometrial Hyperplasia; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies | 2016 |
Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Genistein; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phytoestrogens; Phytotherapy; Plant Extracts; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage | 2010 |
Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Lynestrenol; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progestins; Prospective Studies; Treatment Outcome | 2011 |
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
Topics: Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Safety; Severity of Illness Index | 2003 |
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Uterine Hemorrhage | 2005 |
Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Uterine Hemorrhage | 2006 |
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Topics: Body Mass Index; Bone Density; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Random Allocation; Treatment Outcome | 2006 |
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Risk Assessment; Risk Factors; Treatment Outcome | 2006 |
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biopsy; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1993 |
Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group.
Topics: Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone | 1996 |
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Topics: Administration, Oral; Climacteric; Desogestrel; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Physical Fitness; Placebos; Postmenopause; Progesterone Congeners; Sweating; Uterine Hemorrhage | 1996 |
The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
Topics: Adult; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol Congeners; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Lipids; Middle Aged; Norethindrone; Postmenopause; Progesterone Congeners; Statistics as Topic | 1996 |
Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
Topics: Adult; Aged; Endometrial Hyperplasia; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Prospective Studies; Time Factors; Triptorelin Pamoate | 1999 |
Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy.
Topics: Administration, Cutaneous; Endometrial Hyperplasia; Estradiol; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Norethindrone; Sensitivity and Specificity; Ultrasonography | 1999 |
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1999 |
Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group.
Topics: Biopsy; Endometrial Hyperplasia; Estradiol; Female; Hormone Replacement Therapy; Humans; Incidence; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Time Factors | 1999 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Topics: Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate | 2000 |
The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Topics: Administration, Oral; Adult; Aged; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prevalence; Progesterone Congeners; Prospective Studies; Treatment Outcome | 2000 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
Endometrial effects of transdermal estradiol/norethisterone acetate.
Topics: Administration, Cutaneous; Adult; Aged; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Uterine Hemorrhage; Vagina | 1992 |
[The mechanism of the therapeutic effect of norethisterone in hyperplastic diseases of the endo- and myometrium in women of reproductive age].
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hyperplasia; Leiomyoma; Myometrium; Norethindrone; Polyps; Randomized Controlled Trials as Topic; Reproduction; Uterine Neoplasms | 1990 |
31 other study(ies) available for norethindrone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue.
Topics: Adult; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Norethindrone; Norethindrone Acetate; Polycystic Ovary Syndrome | 2014 |
Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Combined; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Long-Term Care; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2002 |
METROPATHIA HAEMORRHAGICA.
Topics: Endometrial Hyperplasia; Female; Gonadotropins; Gonadotropins, Pituitary; Humans; Menstruation Disturbances; Metabolism; Norethindrone; Progesterone | 1963 |
STEROID COMPOUNDS WITH PROGESTATIONAL ACTIVITY.
Topics: Contraception; Dysmenorrhea; Endometrial Hyperplasia; Endometriosis; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Menorrhagia; Norethindrone; Norethynodrel; Pregnancy; Progestins; Uterine Neoplasms | 1964 |
IATROGENIC ENDOMETRIAL PATTERNS.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dysmenorrhea; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Humans; Hydroxyprogesterones; Iatrogenic Disease; Norethindrone; Norethynodrel; Pathology; Progestins; Toxicology | 1964 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
EFFECT OF NORETHINDRONE ACETATE UPON GONADOTROPIN-INDUCED OVARIAN FUNCTION.
Topics: Amenorrhea; Chorionic Gonadotropin; Drug Therapy; Endometrial Hyperplasia; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Humans; Norethindrone; Norethindrone Acetate; Ovulation; Pharmacology; Pituitary Gland; Pregnanediol; Progesterone; Urine | 1965 |
[Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy. A follow up study].
Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Combined; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Long-Term Care; Middle Aged; Norethindrone; Postmenopause; Prospective Studies | 2003 |
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
[Ultrastructure of cells of hyperplastic endometrium after the direct impact of gestagens].
Topics: Adolescent; Adult; Culture Media; Cytoplasm; Endometrial Hyperplasia; Endometrium; Female; Humans; In Vitro Techniques; Microscopy, Electron; Middle Aged; Norethindrone; Progesterone | 1984 |
The effects of subcutaneous hormone implants during climacteric.
Topics: Adult; Aged; Climacteric; Drug Implants; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Middle Aged; Norethindrone; Testosterone | 1984 |
Procedures in practice. Hormone implantation.
Topics: Climacteric; Delayed-Action Preparations; Endometrial Hyperplasia; Estradiol; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone; Norethindrone; Testosterone; Uterine Hemorrhage | 1980 |
[Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
Topics: Adenocarcinoma; Adolescent; Adult; Drug Evaluation, Preclinical; Endometrial Hyperplasia; Endometrium; Female; Humans; Leiomyoma; Microscopy, Electron; Middle Aged; Norethindrone; Organ Culture Techniques; Precancerous Conditions; Progesterone; Progesterone Congeners; Uterine Neoplasms | 1982 |
[Effect of progesterone and norethisterone on the DNA content in organ cultures of hyperplastically altered endometrium].
Topics: Adolescent; Adult; DNA; Drug Evaluation, Preclinical; Endometrial Hyperplasia; Endometrium; Female; Humans; Middle Aged; Mitotic Index; Norethindrone; Organ Culture Techniques; Progesterone | 1981 |
[Changes in the endometrial proliferative processes under the influence of progesterone and norethisterone in an organ culture].
Topics: Adult; Cell Division; Endometrial Hyperplasia; Endometrium; Female; Humans; Middle Aged; Mitosis; Norethindrone; Organ Culture Techniques; Progesterone; Time Factors | 1980 |
Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes.
Topics: Activins; Adjuvants, Immunologic; Adult; Drug Combinations; Endometrial Hyperplasia; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Injections, Intramuscular; Luteinizing Hormone; Menstruation; Norethindrone; Oligopeptides; Peptides; Progesterone; Thymus Hormones | 1993 |
Endometrial cytology in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Cell Nucleus; Cytodiagnosis; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone | 1998 |
Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
Topics: Adenocarcinoma; Administration, Oral; Aged; Climacteric; Endometrial Hyperplasia; Estradiol Congeners; Female; Humans; Menopause; Middle Aged; Norethindrone; Uterine Neoplasms | 1979 |
Use of hormones in women over forty.
Topics: Aged; Climacteric; Drug Administration Schedule; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Menopause; Middle Aged; Neurotic Disorders; Norethindrone; Vaginitis | 1977 |
Menopausal therapy and endometrial pathology.
Topics: Endometrial Hyperplasia; Estrogens; Female; Humans; Norethindrone | 1978 |
[Structure and ultrastructure of the endometrium with the depot contraceptive Depositon].
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Sequential; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Epithelium; Ethinyl Estradiol; Female; Humans; Norethindrone; Ovulation | 1977 |
Replacement hormone therapy in gonadal dysgenesis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Megestrol; Norethindrone; Polyps; Progestins; Turner Syndrome; Uterine Neoplasms | 1975 |
[Therapy of juvenile adenomatous hyperplasia of the endometrium by progesterone stimulation].
Topics: Adenoma; Adolescent; Adult; Chlormadinone Acetate; Drug Administration Schedule; Endometrial Hyperplasia; Female; Humans; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1989 |
[The effect of norkolut on immune system status in patients with dyshormonal myocardial dystrophy and hyperplastic processes of the uterus].
Topics: Adult; Cardiomyopathies; Endometrial Hyperplasia; Female; Humans; Middle Aged; Norethindrone | 1989 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
[The outlook for the management of endometrial hyperplasia. A preliminary report].
Topics: Adult; Drug Evaluation; Endometrial Hyperplasia; Female; Humans; Middle Aged; Norethindrone; Uterine Hemorrhage | 1987 |
[Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
Topics: Adenocarcinoma; Adult; Aged; Drug Combinations; Drug Evaluation; Endometrial Hyperplasia; Female; Humans; Mestranol; Middle Aged; Norethindrone; Uterine Neoplasms | 1988 |
[Management and evolution of endometrial hyperplasia using small doses of progestational hormones].
Topics: Adolescent; Adult; Chlormadinone Acetate; Dosage Forms; Endometrial Hyperplasia; Female; Humans; Mestranol; Middle Aged; Norethindrone; Progestins | 1969 |
The climacteric.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone | 1973 |
Indications for therapy with progestational agents.
Topics: Breast Diseases; Contraceptives, Oral; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Ethisterone; Ethynodiol Diacetate; Female; Humans; Male; Medroxyprogesterone; Menstruation Disturbances; Mental Disorders; Migraine Disorders; Norethindrone; Progesterone; Progestins; Sexual Dysfunction, Physiological | 1970 |